Latest Stories

O
Why It Moves

Oscar Health (OSCR) Stock Trades Down, Here Is Why

Shares of health insurance company Oscar Health (NYSE:OSCR) fell 2.1% in the morning session after institutional investor Blue Square Asset Management, LLC, disclosed it sold its entire stake in the company. 

Jan 20, 2026
U
Earnings

U.S. Bancorp’s (NYSE:USB) Q4 CY2025: Beats On Revenue

Financial services giant U.S. Bancorp (NYSE:USB) announced better-than-expected revenue in Q4 CY2025, with sales up 5.1% year on year to $7.37 billion. Its non-GAAP profit of $1.26 per share was 6% above analysts’ consensus estimates.

Jan 20, 2026
F
Earnings

Fifth Third Bancorp’s (NASDAQ:FITB) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

Regional banking company Fifth Third Bancorp (NASDAQ:FITB) met Wall Streets revenue expectations in Q4 CY2025, with sales up 4.9% year on year to $2.34 billion. Its GAAP profit of $1.04 per share was 4.9% above analysts’ consensus estimates.

Jan 20, 2026
F
Earnings

Fastenal (NASDAQ:FAST) Posts Q4 CY2025 Sales In Line With Estimates

Industrial supplier Fastenal (NASDAQ:FAST) met Wall Streets revenue expectations in Q4 CY2025, with sales up 11.1% year on year to $2.03 billion. Its GAAP profit of $0.26 per share was in line with analysts’ consensus estimates.

Jan 20, 2026
K
Earnings

KeyCorp’s (NYSE:KEY) Q4 CY2025: Beats On Revenue

Regional banking company KeyCorp (NYSE:KEY) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.5% year on year to $2.01 billion. Its non-GAAP profit of $0.41 per share was 6.3% above analysts’ consensus estimates.

Jan 20, 2026
D
Earnings

D.R. Horton’s (NYSE:DHI) Q4 CY2025: Beats On Revenue

Homebuilder D.R. Horton (NYSE:DHI) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 9.5% year on year to $6.89 billion. The company expects the full year’s revenue to be around $34.25 billion, close to analysts’ estimates. Its GAAP profit of $2.03 per share was 5.9% above analysts’ consensus estimates.

Jan 20, 2026
M
Earnings

3M (NYSE:MMM) Posts Better-Than-Expected Sales In Q4 CY2025

Industrial conglomerate 3M (NYSE:MMM) announced better-than-expected revenue in Q4 CY2025, with sales up 5.6% year on year to $6.13 billion. Its non-GAAP profit of $1.83 per share was 1.7% above analysts’ consensus estimates.

Jan 20, 2026
F
Earnings

Forestar Group (NYSE:FOR) Surprises With Q4 CY2025 Sales

Residential lot developer Forestar Group (NYSE:FOR) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 9% year on year to $273 million. The company expects the full year’s revenue to be around $1.65 billion, close to analysts’ estimates. Its GAAP profit of $0.30 per share was 5.5% below analysts’ consensus estimates.

Jan 20, 2026
P
Earnings

Peoples Bancorp (NASDAQ:PEBO) Posts Better-Than-Expected Sales In Q4 CY2025

Regional banking company Peoples Bancorp (NASDAQ:PEBO) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5.2% year on year to $119.6 million. Its GAAP profit of $0.89 per share was 1.3% above analysts’ consensus estimates.

Jan 20, 2026
B
Earnings Call

BNY’s Q4 Earnings Call: Our Top 5 Analyst Questions

BNY’s fourth quarter results were well received by the market, with management crediting the strong performance to ongoing execution in its platform model, expanded client relationships, and notable progress in digital assets and AI integration. CEO Robin Vince emphasized that the company achieved “record sales performance for the year,” citing new wins in banking as a service and integrated data analytics as key contributors. Expense control and operational leverage also played a role, with CFO Dermot McDonogh highlighting efficiency gains from digitization and automation, as well as investments in new capabilities.

Jan 20, 2026